Sildenafil improves sexual functioning in premenopausal women with type 1 diabetes who are affected by sexual arousal disorder: a double-blind, crossover, placebo-controlled pilot study
No serious adverse events related to
What should I do if I forget to take a dose?
These were self-limited, transient, symptomatic changes distinguished from major depressive disorder relapse and not considered clinically meaningful to warrant intervention. No recurrence or relapse of major depressive disorder occurred in any of the women continuing a stable dose of antidepressants during the trial (Table 2). Mean (SD) baseline values for all endocrine values were within the normal range without significant differences between groups (Table 3). Independent of treatment assignment, a comparison of women whose sexual function improved with those whose sexual function did not improve showed higher mean baseline levels of free testosterone (P ≤ .01) and thyroxine (P ≤ .01) among SRI-associated sexual dysfunction treatment responders. At study end, 76.9% (30 of 39) of women took a mean (SD) dose of 91.7 (19.8) mg of sildenafil and 86.5% (32 of 37) took 93.1 (17.5) mg of placebo. trial medication were reported (Table 4).
- Sildenafil is a medication primarily used to treat erectile dysfunction in men.
- Women sildenafil is an off-label use aimed at improving female sexual arousal.
- Clinical trials are ongoing to assess efficacy of sildenafil for women.
- Side effects of sildenafil may include headaches, flushing, and nasal congestion.
- Women may experience increased blood flow and libido with sildenafil.
- Proper dosage and medical consultation are essential before use.
To our knowledge, this is the first randomized trial to demonstrate a
| Product | Dosage | Quantity + Bonus | Price | |
|---|---|---|---|---|
| Viagra Generic | 150mg | 20 Pills | 55.02€ 52.40€ | |
| Kamagra Soft Tabs | 100mg | 84 + 4 Pills | 233.05€ 221.95€ | |
| Viagra Generic | 25mg | 60 + 4 Pills | 71.99€ 68.56€ | |
| Viagra Generic | 150mg | 120 + 8 Pills | 177.58€ 169.12€ | |
| Kamagra Oral Jelly | 100mg | 21 Sachets | 95.92€ 91.35€ | |
| Kamagra | 100mg | 360 + 6 Pills | 839.95€ 799.95€ | |
| Viagra Generic | 50mg | 20 Pills | 40.52€ 38.59€ | |
| Viagra Generic | 200mg | 10 Pills | 40.96€ 39.01€ | |
| Viagra Generic | 200mg | 180 + 10 Pills | 277.56€ 264.34€ | |
| Viagra Generic | 150mg | 30 + 2 Pills | 72.32€ 68.88€ | |
| Viagra Generic | 50mg | 360 + 10 Pills | 225.33€ 214.60€ | |
| Viagra Generic | 150mg | 270 + 10 Pills | 326.61€ 311.06€ |
significant reduction in adverse sexual effects,
| Factor | Impact | Explanation | Recommendations |
|---|---|---|---|
| Anxiety | Reduced efficacy | Anxiety can impair sexual response | Counseling or therapy suggested |
| Depression | Reduced libido affecting outcomes | Mental health impacts physiological response | Medical treatment advisable |
| Stress | Interferes with arousal | Acute stress can impair drug effectiveness | Stress management techniques |
| Confidence in intimacy | Enhances perceived effectiveness | Positive attitude can improve outcomes | Psychological support recommended |
measured by the Clinical Global Impression sexual
Interested, but not quite ready?
The maximum dose for the study was 100 mg. The mean (SD) number of doses per 2-week interval was 5.0 (2.5) mg for sildenafil and 5.2 (2.5) for placebo, which supports the notion that the lack of efficacy in placebo patients was not due to a lack of attempts (P = .67). The most common adverse event was headache, reported by 43% of women taking sildenafil and 27% taking placebo (P = .09). Less frequent were flushing, 24% vs 0% (P<.001); dyspepsia, 12% vs 0% (P = .01); nasal congestion, 37% vs 6% (P<.001); and transient visual disturbances, 14% vs 2% (P = .03), respectively. Adverse events more common in the placebo group than in the sildenafil group were nausea 16% vs 2% (P = .01) and anxiousness 6% vs 2% (P = .31). function, that compared sildenafil with placebo
Log in or create a free account to read this content
The χ2 analyses were used to evaluate group differences in categorical measures. Analyses were based on intent-to-treat with the last-observation-carried-forward analyses performed on all variables and included data from all protocol-treated patients. All randomized patients received and took at least 1 dose of study trial medication, had at least 1 efficacy assessment, and were included regardless of protocol deviations or whether they completed the study. The final analysis included women who completed the trial, but for the women who did not complete the trial, their baseline value was carried forward in separate analyses. The change in sexual functioning by Clinical Global Impression sexual function score and all other questionnaires from baseline to each patient's own end point were the dependent measures of efficacy.
Altitude sickness
A repeated measures analysis of variance was used to determine differences between placebo and sildenafil in the change from baseline to end point for the measures of efficacy and depression severity (time × group interaction). In addition, exact nonparametric methods were applied to the efficacy measures to substantiate results that rely on distributional assumptions. Findings were also confirmed with analysis of covariance and Wilcoxon rank sum tests for primary analyses. All statistical tests were 2-sided, and all hypotheses were evaluated at the 5% significance level. The F test of the overall hypothesis test was first conducted before multiple comparisons analyses. among women with SRI-associated sexual dysfunction,
| Tip | Explanation | Rationale |
|---|---|---|
| Take on an empty stomach | Food, especially high-fat meals, delays absorption | Ensures faster effect |
| Follow prescribed dosage | Avoid overdose and side effects | Ensures safety and effectiveness |
| Do not mix with nitrates | Risk of severe hypotension | Critical safety warning |
| Monitor for side effects | Report persistent issues to healthcare provider | Ensures prompt management |
| Use with sexual stimulation | Enhances the effectiveness | Maximizes potential benefits |
specifically including delayed orgasm responses and
- Doctors may prescribe sildenafil off-label for women based on individual assessment.
- Patient education about realistic expectations is essential when using sildenafil.
- Sildenafil’s mechanism involves enhancing nitric oxide signaling in blood vessels.
- Women with liver or kidney problems need careful evaluation before sildenafil use.
- Viagra was initially tested for women before focusing on men’s erectile issues.
- Alternative options like vaginal lubricants are also common for female sexual problems.
inadequate lubrication, while continuing stable-dose antidepressant treatment.
Non-medical use
Sample-size calculations were based on detecting a difference in full response rates at 8 weeks, assuming a response rate of 70% for sildenafil and 35% for placebo. Thus, a sample size of 82 evaluable patients (41 per group) was expected to detect a significant difference with 90% power for a type I error rate of α = .05 between sildenafil and placebo (2-sided). Assuming 20% attrition, 100 patients were planned to be randomized and 98 patients were entered. The sample size determination assumed no interactions of treatment with site or antidepressant. The primary analysis was according to assignment at randomization.
Vyleesi (bremelanotide)
In addition to determination of this narrow measure of efficacy based on all randomized patients and imputing the worst rank scores for early exclusions due to protocol violations before and without taking the trial drug, there was a general efficacy analysis for all protocol-treated patients and all trial completers. Adjusted means (SDs) were determined and reported. Where applicable, 95% confidence intervals (CIs) are provided. Analyses were performed with SAS version 9.1.3 (SAS Institute Inc, Cary, North Carolina). One hundred women (Figure) of the 145 screened met eligibility requirements.